• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Pharmacokinetics of calcium antagonists].

作者信息

Richard M O

机构信息

Service de Pharmacologie, CHU de Rouen.

出版信息

Therapie. 1993 Nov-Dec;48 Spec No:651-7.

PMID:8091350
Abstract

Pharmacokinetics of the three main classes of calcium antagonists are similar for resorption, protein binding, hepatic metabolism. However, their plasma elimination half lives differ considerably and distinguishes: those that have a short or intermediate plasma half life (nifedipine, verapamil, diltiazem, nicardipine, nitrendipine, felodipine) with once or twice daily administration, most often thanks to slow-release forms, and those whose administration is once daily, either because of prolonged half-life (amlodipine) or because of prolonged duration of action due to accumulation into the cellular wall (lacidipine). These different formulations ensure better patient compliance and plateau plasma concentrations resulting in better clinical efficacy and fewer side-effects.

摘要

相似文献

1
[Pharmacokinetics of calcium antagonists].
Therapie. 1993 Nov-Dec;48 Spec No:651-7.
2
[Principles of the pharmacokinetics and pharmacodynamics of calcium antagonists].[钙拮抗剂的药代动力学和药效学原理]
Wien Med Wochenschr. 1993;143(19-20):490-500.
3
Lercanidipine: short plasma half-life, long duration of action and high cholesterol tolerance. Updated molecular model to rationalize its pharmacokinetic properties.乐卡地平:血浆半衰期短、作用持续时间长且胆固醇耐受性高。更新分子模型以阐明其药代动力学特性。
Blood Press Suppl. 1998;2:10-7.
4
The kinetic profiles of amlodipine and of a sustained release form of diltiazem.
Therapie. 1998 Mar-Apr;53(2):121-6.
5
[Clinical pharmacology of calcium inhibitors].[钙通道阻滞剂的临床药理学]
Arch Mal Coeur Vaiss. 1985 Nov;78 Spec No:15-22.
6
[Pharmacokinetics and pharmacodynamics of calcium channel blockers].[钙通道阻滞剂的药代动力学和药效学]
Vnitr Lek. 1995 Mar;41(3):164-6.
7
Clinical pharmacokinetics of calcium channel antagonists.
J Cardiovasc Pharmacol. 1982;4 Suppl 3:S340-5.
8
Amlodipine: a new calcium antagonist.氨氯地平:一种新型钙拮抗剂。
Am J Hosp Pharm. 1994 Jan 1;51(1):59-68.
9
Amlodipine: pharmacokinetic profile of a low-clearance calcium antagonist.
J Cardiovasc Pharmacol. 1991;17 Suppl 1:S4-7.
10
Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension.从缓释型钙通道阻滞剂转换为速释型钙通道阻滞剂:轻至中度高血压患者的转归
Clin Ther. 1993 Nov-Dec;15(6):1002-10.